You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(01558.HK)將與111集團旗下壹號藥業緊密合作探索醫藥新型業務模式
格隆匯 12-09 20:42

格隆匯12月9日丨東陽光藥(01558.HK)發佈公告,近日公司與111集團旗下的廣東壹號藥業有限公司分別於2019年11月及2019年12月簽署兩份戰略合作框架協議,據此,壹號藥業將就該公司心腦血管、內分泌及抗病毒等領域產品在藥品銷售與推廣、在線展示及用户健康大數據精準分析等方面,協助該公司提升品牌認知及市場份額。

壹號藥業將在其服務覆蓋的廣闊市場中,積極協助該公司進行患者教育、品牌建設等工作。公司將與壹號藥業通過緊密合作,推進供銷一體化、規模化效應,並積極探索醫-藥-患-保的新型業務模式,促進合作雙方、終端及消費者等多方受益。戰略合作框架協議的合作期限為三年。

111集團是一家線上線下一體化的醫藥健康平台,通過以科技賦能商業服務大眾(T2B2C)模式,擁有一體化的醫藥健康平台和生態圈。111集團為一家於美國納斯達克交易所(NASDAQ)掛牌上市的公司,股票代碼YI。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account